Danazol inhibits aromatase activity of endometriosis-derived stromal cells by a competitive mechanism

Fertility and Sterility

Volumn 86, Issue 2, 2006, Pages 291-297

  Murakami, Koichi ^a   Nomura, Kazuhito ^a   Shinohara, Kazunori ^a   Kasai, Tadayuki ^a   Shozu, Makio ^a   Inoue, Masaki ^a  

^a KANAZAWA UNIVERSITY   (Japan)

Author keywords

aromatase; competitor; danazol; Endometriosis

Indexed keywords

AROMATASE; DANAZOL; ESTROGEN; MESSENGER RNA; PROSTAGLANDIN E2;

ARTICLE; CELL CULTURE; COMPETITIVE INHIBITION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG EFFECT; ENDOMETRIOSIS; ENDOMETRIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; ESTROGEN SYNTHESIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MICROSOME; OVARY CYST; PRIORITY JOURNAL; PROTEIN EXPRESSION; RANDOMIZATION; STROMA CELL;

AROMATASE; AROMATASE INHIBITORS; BLOTTING, WESTERN; CELLS, CULTURED; DANAZOL; ENDOMETRIOSIS; FEMALE; HUMANS; KINETICS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STROMAL CELLS;

EID: 33746383106     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2005.12.074     Document Type: Article

References (28)

1. Simpson E.R. Aromatase; biological relevance of tissue-specific expression. Semin Reprod Med 22 (2004) 11-23
2. Noble L.S., Simpson E.R., Johns A., and Bulun S.E. Aromatase expression in endometriosis. J Clin Endocrinol Metab 81 (1996) 174-179
3. 2 stimulates aromatase expression in endometriosis-derived stromal cells. J Clin Endocrinol Metab 82 (1997) 600-606
4. Bulum S.E., Fang Z., Imir G., Gurates B., Tamura M., Yilmaz B., et al. Aromatase and endometriosis. Semin Reprod Med 22 (2004) 45-50
5. Ailawadi R.K., Jobanputra S., Kataria M., Gurates B., and Bulun S.E. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate. a pilot study. Fertil Steril 81 (2004) 290-296
6. Amsterdam L.L., Gentry W., Jobanputra S., Wolf M., Rubin S.D., and Bulun S.E. Anastrazole and oral contraceptives. a novel treatment for endometriosis. Fertil Steril 84 (2005) 300-304
7. Nomura K., Murakami K., Shozu M., Nakama T., Yui N., and Inoue M. Local application of danazol-loaded hyaluronic acid hydrogel to endometriosis in a rat model. Fertil Steril 85 S1 (2006) 1157-1167
8. Simon C., and Gracia-Velasco J. Medical treatment of endometriosis. Gynecol Obstet Invest 57 (2004) 51-52
9. von Fallois J., Etterli-Billenkamp U., Schindler E.M., and Schindler A.E. Danazol for treatment of fibrocystic mastopathy. (in German). Zentralbl Gynekol1 17 (1995) 457-465
10. Sadek I., Zayed E., Hayne O., and Fernandez L. Prolonged complete remission of myelodysplastic syndrome treated with danazol, retinotic acid and low-dose predonisorone. Am J Hematol 64 (2000) 306-310
11. Maloisel F., Andres E., Zimmer J., Noel E., Zamfir A., Koumarianou A., et al. Danazol therapy in patients with chronic idiopathic thrombocytopenic purpura. long-term results. Am J Med 116 (2004) 590-594
12. Franchimont P., and Cramilion C. The effect of danazol on anterior pituitary function. Fertil Streil 28 (1977) 814-817
13. Barbieri R.L., Canick J.A., Makris A., Todd R.B., Davis I.J., and Ryan K.J. Danazol inhibits steroidogenesis. Fertil Steril 28 (1977) 809-813
14. Vigano P., DiBlasio A.M., Busacca M., and Vignali M. Immunosuppressive effect of danazol lymphocyte-mediated cytotoxicity toward human endometrial stromal cells. Gynecol Endocrinol 8 (1994) 13-19
15. Rose G.L., White J.O., Dowsett M., Jeffcoate S.L., and Mudge J.E. The inhibitory effects of danazol, danazol metabolites, gestrinone, and testosterone on the growth of human endometrial cells in vitro. Fertil Steril 49 (1988) 224-228
16. Barbieri R, Lee H, Ryan KJ. Danazol binding to rat androgen, glucocorticoid, progesterone, and estrogen receptors: correlation with biological activity. Fertil Steril 18779;31:182-6.
17. Barbieri R.L., Osathanondh R., and Ryan K.J. Danazol inhibition of steroidogenesis in the human corpus luteum. Obstet Gynecol 57 (1981) 722-724
18. Tsang B.K., Henderson K.M., and Armstrong D.T. Effect of danazol on estradiol-17b and progesterone secretion by porcine ovarian cells in vitro. Am J Obstet Gynecl 133 (1979) 256-259
19. Olsson J.H., Hillensjo T., and Nillson L. Inhibitor effects of danazol on steroidogenesis in cultured human granulosa cells. Fertil Steril 46 (1986) 237-242
20. Ishihara H., Kitawaki J., Kado N., Koshiba H., Fushiki S., and Honjo H. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril 79 (2003) 735-742
21. Mor G., Eliza M., Song J., Wiita B., Chen S., and Naftolin F. 17a-Methyl testosterone is a competitive inhibitor of aromatase activity in Jar choriocarcinoma cells and macrophage-like THP-1 cells in culture. J Steroid Biochem Mol Biol 79 (2001) 239-246
22. Ryan I., Schriock E.D., and Taylor R. Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab 78 (1994) 642-649
23. Sumitani H., Shozu M., Segawa T., Murakami K., Yang H.J., Shimada K., et al. In situ estrogen synthesized by aromatase P450 in uterine leiomyoma cells promotes cell growth probably via an autocrine/intracrine mechanism. Endocrinology 141 (2000) 3852-3861
24. Yang H.J., Shozu M., Murakami K., Sumitani H., Segawa T., Kasai T., et al. Spacially heterogenous expression of aromatase P450 through promoter II is closely correlated with the level of steroidogenic facrtor-1 transcript in endometrioma tissues. J Clin Endocrinol Metab 87 (2002) 3745-3753
25. Terakawa N. Studies on endocrine therapy for endometriosis. Acta Obstet Gynec Jpn 41 (1989) 981-989
26. Urabe M., Yamamoto T., Kitawaki J., Honjo H., and Okada H. Estrogen biosynthesis in human uterine adenomyosis. Acta Endocrinologica 121 (1989) 259-264
27. Boos C.J., Dawes M., Jones R., and Farrell T. Danazol treatment and acute myocardial infarction. J Obstet Gynaecol 23 (2003) 327-328
28. Horstmen L.L., Jy W., Arce M., and Ahm Y.S. Danazol distribution in plasma and cell membranes as related to altered cell properties. implications for mechanism. Am J Hematol 5 (1995) 179-187